rosiglitazone has been researched along with Injury, Myocardial Reperfusion in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (55.56) | 29.6817 |
| 2010's | 8 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Hu, Q; Jiang, C; Liu, HF | 1 |
| Grotemeyer, D; Mersmann, J; Tran, N; Zacharowski, K; Zacharowski, PA | 1 |
| Abe, M; Ichimaru, S; Kaji, S; Takiguchi, Y; Tsuchiya, K; Wada, K | 1 |
| Christopher, TA; Gao, E; Koch, W; Lau, WB; Liu, HR; Lopez, BL; Ma, XL; Qu, Y; Tao, L; Yue, TL | 1 |
| Dong, YG; Ma, H; Ma, YD; Tang, AL; Wu, JG; Xiong, ZB; Zhang, XJ | 1 |
| Hu, Z; Lin, Y; Perez-Polo, JR; Ye, Y; Zhang, C | 1 |
| Chattipakorn, N; Chattipakorn, S; Palee, S; Surinkeaw, S; Weerateerangkul, P | 1 |
| Li, J; Morrison, A; Tong, C; Yan, X | 1 |
| Cai, Q; Gao, Z; Liang, G; Liu, B; Liu, D; Xu, G | 1 |
| Chattipakorn, N; Chattipakorn, SC; Chinda, K; Palee, S; Weerateerangkul, P | 1 |
| Gao, XQ; Gao, Y; Li, HW; Ling, X; Qiu, YH; Zhang, Y | 1 |
| Christopher, TA; Gao, E; Liu, HR; Lopez, BL; Ma, XL; Ohlstein, EH; Tao, L; Willette, RN; Yue, TL | 1 |
| Ahmad, H; Brown, RD; Fox, J; Gen, M; Greyson, C; Long, CS; Lu, L; Perlov, D; Schwartz, GG; Weiss, SO; Xu, Y; Zhu, P | 1 |
| Bao, W; Cui, J; Gu, JL; Jucker, BM; Ma, XL; Ohlstein, EH; Tao, L; Yue, TL | 1 |
| Ao, Z; Costell, M; Douglas, SA; Eybye, M; Gruver, S; Johns, DG; Macphee, CH; Olzinski, A; Smith, SA | 1 |
| Bao, W; Boyce, R; Bril, A; Buckingham, RE; Chen, J; Gu, JL; Hart, TK; Jiang, W; Lysko, PG; Narayanan, PK; Ohlstein, EH; Yue Tl, TL; Zimmerman, DM | 1 |
| Berrebi-Bertrand, I; Bril, A; Buckingham, RE; Delerive, P; Khandoudi, N; Staels, B | 1 |
| Chatterjee, PK; Cuzzocrea, S; Hattori, Y; McDonald, MC; Mota-Filipe, H; Pisano, B; Thiemermann, C; Wayman, NS | 1 |
1 trial(s) available for rosiglitazone and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
Effect of rosiglitazone on rabbit model of myocardial ischemia-reperfusion injury.
Topics: Animals; C-Reactive Protein; Creatine Kinase; Creatine Kinase, MB Form; Disease Models, Animal; Endothelins; Glutathione Peroxidase; Heart; Hypoglycemic Agents; Male; Malondialdehyde; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Rabbits; Rosiglitazone; Superoxide Dismutase; Thiazolidinediones; Treatment Outcome | 2013 |
17 other study(ies) available for rosiglitazone and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
Effect of peroxisome proliferator-activated receptor gamma agonist on heart of rabbits with acute myocardial ischemia/reperfusion injury.
Topics: Animals; Biomarkers; C-Reactive Protein; Creatine Kinase, MB Form; Endothelins; Heart; Male; Malondialdehyde; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Oxidoreductases; PPAR gamma; Rabbits; Rats; Rosiglitazone; Thiazolidinediones; Troponin I | 2014 |
Rosiglitazone is cardioprotective in a murine model of myocardial I/R.
Topics: Animals; Cell Line; Heme Oxygenase (Decyclizing); Male; Mice; Mice, Inbred C57BL; Myocardial Reperfusion Injury; Oxidative Stress; Rats; Rosiglitazone; Thiazolidinediones | 2008 |
Different effect of acute treatment with rosiglitazone on rat myocardial ischemia/reperfusion injury by administration method.
Topics: Acetylcysteine; Animals; Antioxidants; Computer Simulation; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; I-kappa B Proteins; Infusions, Intravenous; Injections, Intravenous; Male; Models, Biological; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; NF-kappa B; Peroxidase; Phosphorylation; PPAR gamma; Protective Agents; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2008 |
Rosiglitazone inhibits hypercholesterolaemia-induced myeloperoxidase upregulation--a novel mechanism for the cardioprotective effects of PPAR agonists.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Caspase 3; Gene Expression Regulation, Enzymologic; Hypercholesterolemia; Intercellular Adhesion Molecule-1; Lipoproteins, LDL; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Peroxidase; PPAR gamma; Rabbits; Rosiglitazone; Thiazolidinediones | 2009 |
Rosiglitazone-induced myocardial protection against ischaemia-reperfusion injury is mediated via a phosphatidylinositol 3-kinase/Akt-dependent pathway.
Topics: Androstadienes; Animals; Blood Glucose; Glycogen Synthase Kinase 3; Male; Mice; Myocardial Infarction; Myocardial Reperfusion Injury; Phosphatidylinositol 3-Kinases; PPAR gamma; Proto-Oncogene Proteins c-akt; Rats; Rosiglitazone; Thiazolidinediones; Ventricular Fibrillation; Wortmannin | 2010 |
Downregulation of microRNA-29 by antisense inhibitors and a PPAR-gamma agonist protects against myocardial ischaemia-reperfusion injury.
Topics: Anilides; Animals; Apoptosis; bcl-2-Associated X Protein; Blotting, Northern; Blotting, Western; Caspase 3; Cell Line; Cell Survival; Disease Models, Animal; Down-Regulation; Gene Expression Profiling; Mice; MicroRNAs; Myeloid Cell Leukemia Sequence 1 Protein; Myocardial Reperfusion Injury; Myocardium; Oligonucleotide Array Sequence Analysis; Oligonucleotides, Antisense; Phosphorylation; Pioglitazone; PPAR gamma; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Rats; Rosiglitazone; Thiazolidinediones; Time Factors; Transfection | 2010 |
Effect of rosiglitazone on cardiac electrophysiology, infarct size and mitochondrial function in ischaemia and reperfusion of swine and rat heart.
Topics: Animals; Cardiac Electrophysiology; Coronary Circulation; Coronary Vessels; Electric Countershock; Female; Heart; Male; Membrane Potential, Mitochondrial; Mitochondria, Heart; Myocardial Infarction; Myocardial Reperfusion Injury; Rats; Reactive Oxygen Species; Rosiglitazone; Swine; Thiazolidinediones; Ventricular Fibrillation | 2011 |
Acute rosiglitazone treatment is cardioprotective against ischemia-reperfusion injury by modulating AMPK, Akt, and JNK signaling in nondiabetic mice.
Topics: AMP-Activated Protein Kinases; Anilides; Animals; Cardiotonic Agents; Disease Models, Animal; Drug Administration Schedule; Enzyme Activation; Injections, Intravenous; JNK Mitogen-Activated Protein Kinases; Male; Mice; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Phosphorylation; PPAR gamma; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrazoles; Pyrimidines; Rosiglitazone; Signal Transduction; Thiazolidinediones; Time Factors; Ventricular Function, Left; Ventricular Pressure | 2011 |
Intervention of rosiglitazone on myocardium Glut-4 mRNA expression during ischemia-reperfusion injury in cardio-pulmonary bypass in dogs.
Topics: Animals; Blood Glucose; Cardioplegic Solutions; Cardiopulmonary Bypass; Dogs; Gene Expression; Glucose Transporter Type 4; Heart Ventricles; Insulin; Insulin Resistance; Myocardial Reperfusion Injury; PPAR gamma; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Ventricular Pressure | 2013 |
Mechanisms responsible for beneficial and adverse effects of rosiglitazone in a rat model of acute cardiac ischaemia-reperfusion.
Topics: Animals; Arrhythmias, Cardiac; Calcium; Caspase 3; Caspase 8; Heart; Male; Mitochondria, Heart; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocytes, Cardiac; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones | 2013 |
Anti-apoptotic effects of rosiglitazone in hypercholesterolemic rabbits subjected to myocardial ischemia and reperfusion.
Topics: Animals; Apoptosis; Diet; Enzyme Induction; Hypercholesterolemia; In Situ Nick-End Labeling; Male; MAP Kinase Signaling System; Myocardial Ischemia; Myocardial Reperfusion Injury; Nitric Oxide; Rabbits; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazolidinediones; Transcription Factors | 2004 |
PPAR-gamma activation fails to provide myocardial protection in ischemia and reperfusion in pigs.
Topics: alpha-Tocopherol; Animals; Antioxidants; Chromans; Coronary Circulation; Cytokines; Energy Metabolism; Fatty Acids, Nonesterified; Female; Hypoglycemic Agents; Male; Myocardial Contraction; Myocardial Reperfusion Injury; Myocardium; PPAR gamma; RNA, Messenger; Rosiglitazone; Sus scrofa; Thiazolidinediones; Troglitazone; Ventricular Function, Left | 2005 |
Rosiglitazone treatment in Zucker diabetic Fatty rats is associated with ameliorated cardiac insulin resistance and protection from ischemia/reperfusion-induced myocardial injury.
Topics: Administration, Oral; Animals; Blood Glucose; Coronary Vessels; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Heart; Hypoglycemic Agents; Insulin Resistance; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Rats; Rats, Zucker; Rosiglitazone; Thiazolidinediones; Triglycerides | 2005 |
Rosiglitazone protects against ischemia/reperfusion-induced leukocyte adhesion in the zucker diabetic fatty rat.
Topics: Adiponectin; Animals; Blood Glucose; Blood Pressure; Cell Adhesion; Fatty Acids, Nonesterified; Hypoglycemic Agents; Immunohistochemistry; Insulin; Leukocytes; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Rats; Rats, Zucker; Rosiglitazone; Thiazolidinediones; Vascular Cell Adhesion Molecule-1 | 2005 |
In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.
Topics: Animals; CD18 Antigens; Cell Adhesion Molecules; Chemokine CCL2; Diabetes Complications; Hypoglycemic Agents; Macrophage-1 Antigen; Macrophages; Male; Monocytes; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion Injury; Neutrophil Infiltration; Neutrophils; Rats; Rats, Inbred Lew; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors | 2001 |
Rosiglitazone, a peroxisome proliferator-activated receptor-gamma, inhibits the Jun NH(2)-terminal kinase/activating protein 1 pathway and protects the heart from ischemia/reperfusion injury.
Topics: Animals; Cardiotonic Agents; Carrier Proteins; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose; Glucose Transporter Type 4; Hypoglycemic Agents; In Vitro Techniques; Intracellular Signaling Peptides and Proteins; JNK Mitogen-Activated Protein Kinases; Lactic Acid; Male; Mitogen-Activated Protein Kinases; Monosaccharide Transport Proteins; Muscle Proteins; Myocardial Reperfusion Injury; Myocardium; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors | 2002 |
Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size.
Topics: Adult; Animals; Cardiotonic Agents; Cell Adhesion Molecules; Cell Line; Cells, Cultured; Chemokine CCL2; Clofibrate; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Humans; Ligands; Male; Membrane Proteins; Myocardial Infarction; Myocardial Reperfusion Injury; Pioglitazone; Prostaglandin D2; Prostaglandins A; Protein Isoforms; Pyrimidines; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors | 2002 |